Trials / Recruiting
RecruitingNCT06504927
Biomarker Discovery in Lung Cancer - Malaysia
- Status
- Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 400 (estimated)
- Sponsor
- University of Malaya · Academic / Other
- Sex
- All
- Age
- 30 Years
- Healthy volunteers
- Accepted
Summary
This study aims to 1. Identify biomarkers and signatures to differentiate between high-risk and lung cancer patients. 2. Discover blood-based biomarkers that can be used as an adjunct test to imaging diagnosis to improve patient follow-up.
Detailed description
With existing evidence showing the utility of using liquid biopsy for early cancer detection, the investigators hypothesized that cell-free DNA and/or RNA expression changes during disease progression, and biomarker signature can be derived from the changes in expression levels. The investigators aim to discover and validate RNA and methylated cell-free DNA cancer biomarkers that can discriminate between high-risk and lung cancer patients.
Conditions
Timeline
- Start date
- 2024-01-16
- Primary completion
- 2026-12-31
- Completion
- 2026-12-31
- First posted
- 2024-07-17
- Last updated
- 2024-07-18
Locations
1 site across 1 country: Malaysia
Source: ClinicalTrials.gov record NCT06504927. Inclusion in this directory is not an endorsement.